Showing results (1-10 of 84) with videos related to
Sort By:
Pageof 9
World Journal of Urology|April 8, 2017
Alfuzosin: a clinically uroselective α<sub>1</sub>-blockerKlaus Höfner, Udo JonasWorld Journal of Urology|May 23, 2002
Alfuzosin: a clinically uroselective alpha1-blockerKlaus Höfner, Udo JonasWorld Journal of Urology|May 23, 2002
Increase in detrusor wall thickness indicates bladder outlet obstruction (BOO) in menMatthias Oelke, Klaus Höfner, Birgitt Wiese, et al.Restorative Neurology and Neuroscience|April 3, 2003
Sacral electrical neuromodulation as an alternative treatment option for lower urinary tract dysfunctionVolker Grünewald, Klaus Höfner, Walter F. Thon, et al.Neurourology and Urodynamics|May 3, 2006
Ultrasound measurement of detrusor wall thickness in healthy adultsMatthias Oelke, Klaus Höfner, Udo Jonas, et al.European Urology|March 8, 2008
Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasiaMatthias Oelke, Joyce Baard, Hessel Wijkstra, et al.European Urology|January 9, 2007
Diagnostic accuracy of noninvasive tests to evaluate bladder outlet obstruction in men: detrusor wall thickness, uroflowmetry, postvoid residual urine, and prostate volumeMatthias Oelke, Klaus Höfner, Udo Jonas, et al.Aktuelle Urologie|January 13, 2017
[Prostate Carcinoma Mimics Lung Carcinoma: A Case Report]Konstantinos Drosos, Klaus HöfnerWorld Journal of Urology|August 20, 2014
Impact of desmopressin on nocturia due to nocturnal polyuria in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)Richard Berges, Klaus Höfner, Michael Gedamke, et al.BJU International|December 13, 2005
Long-term therapy with the dual 5alpha-reductase inhibitor dutasteride is well tolerated in men with symptomatic benign prostatic hyperplasiaClaude Schulman, Peter Pommerville, Klaus Höfner, et al.Pageof 9